Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
2024 · Journal of Hepatology · 53 citations
https://doi.org/10.1016/j.jhep.2024.05.033
J
Jesús Rivera‐Esteban
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
659
Citations
14
h-index
18
i10-index
Jesús Rivera‐Esteban is an academic researcher from Hospital Universitario Puerta de Hierro Majadahonda. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Liver Diseases and Immunity. The author has an h-index of 14, co-authored 34 publications.
ORCID: 0000-0003-4357-8817Papers by this author
worksPoint-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease
2023 · Clinical Gastroenterology and Hepatology · 43 citations
https://doi.org/10.1016/j.cgh.2023.08.004
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
2023 · EClinicalMedicine · 35 citations
https://doi.org/10.1016/j.eclinm.2023.102384
Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma
2024 · Clinical Gastroenterology and Hepatology · 28 citations
https://doi.org/10.1016/j.cgh.2024.03.028
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
2024 · United European Gastroenterology Journal · 20 citations
https://doi.org/10.1002/ueg2.12534
Accuracy of a sequential algorithm based on FIB-4 and ELF to identify high-risk advanced liver fibrosis at the primary care level
2023 · Internal and Emergency Medicine · 7 citations
https://doi.org/10.1007/s11739-023-03441-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat